AstraZeneca vs CHoRUS for Equitable AI

AstraZeneca (Data and AI: Unlocking new science insights) and CHoRUS for Equitable AI both appear on the Smoower Developer Ecosystem Index.

AstraZeneca (rank #510) holds a modest lead over CHoRUS for Equitable AI (rank #881) on the overall Smoower ecosystem score (37 vs 25). The gap of 12 points reflects composite signals across code, docs, community and reach.

On code quality (the state of repositories, tests, releases and polish), AstraZeneca is clearly ahead of CHoRUS for Equitable AI. On education (docs, guides and learning material for developers), AstraZeneca is clearly ahead of CHoRUS for Equitable AI. On community (issue response, PR reviews and discussion health), CHoRUS for Equitable AI is slightly ahead of AstraZeneca. On reach (how visible the ecosystem is beyond its own repos), CHoRUS for Equitable AI is ahead of AstraZeneca. On momentum (release cadence and how fast the ecosystem moves), AstraZeneca is clearly ahead of CHoRUS for Equitable AI.

AstraZeneca carries 5,180 GitHub stars across 107 public repos, with 22 repositories active in the last 90 days and 2 external contributors on record. CHoRUS for Equitable AI shows 27 stars across 28 public repos, 5 active in the last 90 days and 3 external contributors. The star gap on its own does not decide the comparison, but AstraZeneca's footprint is roughly 191.9x larger, which usually shows up in downstream signals like inbound issues and third party integrations.

AstraZeneca is the stronger read for anyone weighting education. CHoRUS for Equitable AI looks better where reach is the deciding factor. The table below breaks the scores down pillar by pillar; the linked profiles cover the underlying repos, docs and community signals in full.